What amount sold does TruTag Technologies, Inc. report in Form D filings?

The latest linked filings report $42.2M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was TruTag Technologies, Inc.'s most recent SEC filing?

TruTag Technologies, Inc.'s most recent Form D filing was on 2019-09-03.

How many investors does TruTag Technologies, Inc. have?

The most recent Form D filing lists 30 investor(s).

What type of securities does TruTag Technologies, Inc. offer?

TruTag Technologies, Inc.'s SEC Form D filings indicate equity offerings.

TruTag Technologies, Inc.

CIK: 0001560969·Pharmaceuticals·EMERYVILLE, CA·Corporation

Reported Sold

$42,247,640

Total Filings

Identified Offerings

Last Filed

Sep 3, 2019

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Sep 3, 2019Form D — New notice

Reported sold: $25,471,113 · Target: $43,055,938

Rule 506(b)·30 investors

Jun 13, 2014Form D/A — Amendment

Reported sold: $16,776,527 · Target: $17,413,518

Rule 506(b)·53 investors

Changed: Reported amount sold, Offering target, Reported investors, Sales commissions, Exemptions

Oct 26, 2012Form D/A — Amendment

Reported sold: $9,276,568 · Target: $12,762,030

Rule 506·52 investors

Changed: Offering target

Oct 25, 2012Form D — New notice

Reported sold: $9,276,568 · Target: $12,275,039

Rule 506·52 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$299,685

Amendment Rate

50%

Latest reported sold across 2 identified offerings

$42,247,640

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Michael Bartholomeusz

Related Person

Appears on 1 filing

Leslie Leff

Related Person

Appears on 1 filing

Michael O'Neill, Ph.D.

Related Person

Appears on 1 filing

Peter M. O. Wong

Related Person

Appears on 1 filing

Gregory Leong

Related Person

Appears on 1 filing

Albert Pleus

Related Person

Appears on 1 filing

Mark Maciejewski

Related Person

Appears on 1 filing

James Pappas

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 3, 2019	New	$43,055,938	$25,471,113	30
Jun 13, 2014	Amendment	$17,413,518	$16,776,527	53
Oct 26, 2012	Amendment	$12,762,030	$9,276,568	52
Oct 25, 2012	New	$12,275,039	$9,276,568	52

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Vesalius Longevity Labs Inc.

Pharmaceuticals

Offering target: $30,112,500

Filed Nov 3, 2026